Watt 100 charger Ports Power USB and Adapter AC with Inverter Power 110V Ad car Power Inverters


  1. Home
  2. Watt 100 charger Ports Power USB and Adapter AC with Inverter Power 110V Ad car
  1. facebook
  2. twitter
  3. linkedin
  4. pinterest
100 Watt  charger car Ad 110V Power Inverter with AC Adapter and USB Power Ports
Condition: New: A brand-new, unused, unopened, undamaged item in its original packaging (where packaging is Brand:

Unbranded/Generic

MPN:

Does Not Apply

UPC:

Does not apply




published on tue nov 09 2021

Watt 100 charger Ports Power USB and Adapter AC with Inverter Power 110V Ad car Power Inverters

gandhi, s., klein, j., robertson, a., pena-hernandez, m. a.,

Watt 100 charger Ports Power USB and Adapter AC with Inverter Power 110V Ad car Power Inverters

lin, m. j., roychoudhury, p., lu, p., fournier, j., ferguson, d., mohamed bakhash, s. a., muenker, m. c., srivathsan, a., wunder, e. a., kerantzas, n., wang, w., pyle, a., wilen, c. b., ogbuagu, o., greninger ,, a. l., iwasaki, a., schulz, w. l., ko, a. i.

sars-cov-2 remdesivir resistance mutations have been generated in vitro but have not been reported in patients receiving treatment with the antiviral agent. we present a case of an immunocompromised patient with acquired b-cell deficiency who developed an indolent, protracted course of sars-cov-2 infection. remdesivir therapy alleviated symptoms and produced a transient virologic response, but her course was complicated by recrudescence of high-grade viral shedding. whole genome sequencing identified a mutation, e802d, in the nsp12 rna-dependent rna polymerase which was not present in pre-treatment specimens. in vitro experiments demonstrated that the mutation conferred a ~6-fold increase in remdesivir ic50 but resulted in a fitness cost in the absence of remdesivir. sustained clinical and virologic response was achieved after treatment with casirivimab-imdevimab. although the fitness cost observed in vitro may limit the risk posed by e802d,

, this case illustrates the importance of monitoring for remdesivir resistance and the potential benefit of combinatorial therapies in immunocompromised patients with sars-cov-2 infection.

509
1.2k
EVGENIA.RU RSS